SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

One Ultrasound Scan Flags Both MASH and Liver Scarring

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT Surpasses MRI in Vertebral Bone Quality Assessment

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Latest News

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

A pediatric endocrinologist raises questions about use in youth without diabetes.

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

News All Time

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

More US Employers to Drop Weight-loss Drugs in 2027, as Healthcare Costs Increase

About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see ⁠rising healthcare costs, according to a survey released on...

Trump's Weight; Fauci Gets a Legal Defense Fund; Eye Drops Recalled

— Health news and commentary gathered by MedPage Today staff

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Judge Questions Hegseth's Testosterone Policy Amid Military's Transgender Care Ban

Parties ordered to address "similarities and differences in administering TRT" to both groups

FDA Panel Endorses Lifting Restrictions on Peptides Backed by RFK Jr.

Votes go against agency scientists' recommendation to keep them off the compounding list

1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid

Health news and commentary gathered by MedPage Today staff

Even Short Bouts of Antipsychotics Linked to Diabetes Risk

Risks rose through year 5 in youths, but were seen after even just 1 year

Surgery Underused for Primary Hyperparathyroidism With End-Organ Damage, Study Says

Large study highlights gap between guidelines and clinical practice

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence

News and commentary from the endocrinology world

Florida Investigates Fauci; Obesity Drug Trial Sparks Lawsuit; 'Early Bird' Dinners

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

Breast Cancer Incidence Rises in Asian American Women

Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.

Decoding calcifications in breast cancer: Towards personalized medicine

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Recommended Articles For You

Metabolic Heterogeneity Driving Tumor Progression 

Prognostic Patterns of Functional Recovery During Long-Term Cancer Survivorship 

Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant 

Emerging Therapies Through Personalized Tumor Ecosystem Remodeling 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Telemedicine Not Reaching Rural Psychiatric Patients

2.

Loneliness and social isolation linked to heightened risk of death in those with cancer

3.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

4.

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

5.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

1.

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer

2.

Quality of Life Following Functional Restoration of Bone Marrow Reserve

3.

Tumor Microenvironment Reprogramming Through Stromal Modulation

4.

Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy

5.

Evolutionary Intelligence for Oncology Research Optimization

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

2.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

3.

Navigating the Complexities of Ph Negative ALL - Part II

4.

Recognizing Symptoms That May Require Cancer Evaluation

5.

Diagnosis and Management in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot